What's new in gastric carcinoma? One year review;Quoi de neuf dans le cancer de l'estomac? Photographie de la litterature d'une annee

Journal de Chirurgie

Volumn 135, Issue 4, 1998, Pages 148-154

  Perrot, L ^a   Champault, G ^a  

^a HÔPITAL JEAN VERDIER   (France)

Author keywords

Adenocarcinoma; Review; Stomach

Indexed keywords

ADVANCED CANCER; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURGERY; DIAGNOSTIC IMAGING; EARLY CANCER; HELICOBACTER PYLORI; HUMAN; LAPAROSCOPIC SURGERY; PROGNOSIS; REVIEW; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

CARCINOMA; ENDOSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LAPAROSCOPY; LYMPH NODE EXCISION; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VIDEO RECORDING;

EID: 0031786904     PISSN: 00217697     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Allgayer H, Heiss MM, Schildberg FW. Review of prognostic factors in gastric cancer. Br J Surg 1997;84:1651-1664.
2. Kitamura K, Yamaguchi T, Sawai K et al. Chronologic changes in the clinicopathologic findings and survival of gastric cancer patients. J Clin Oncol 1997;12:3471-3480.
3. Mc Culloch P, Taggart T, Ochiai A, O'Dowd G, Nash J, Sasako M. c-erB2 and p53 expression are not associated with stage progression of gastric cancer in Britain or Japan. Eur J Surg Oncol 1997;23:304-309.
4. Mc Farlane GA, Munro A. Helicobacter Pylori and gastric cancer. Br J Surg 1997; 84:1190-1199.
5. Asaka M, Takeda H, Sugiyama T, Kato M. What role does Helicobacter Pylori play in gastric cancer? Gastroenterology 1997;113: S56-S60.
6. Uemura N, Mukai T, Okamoto S et al. Effect of Helicobacter Pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol Biomarkers Prev 1997;8:639-642.
7. Lee J, O'Morain C. Who should be treated for Helicobacter Pylori infection ? A review of consensus conferences and guidelines. Gastroenterology 1997;113:S99-S106.
8. Davies J, Chalmers AG, Sue-ling HM et al. Spiral computed tomography and operative staging of gastric carcinoma : a comparison with histopathological staging. Gut 1997;41: 314-319.
9. Latif A. Gastric cancer. Update on diagnosis, staging and therapy. Postgrad Med 1997;4: 231-237.
10. Yanai H, Matsumoto V, Harada T et al. Endoscopic ultrasonography and endoscopy for staging depth of invasion in early gastric cancer: a pilot study. Gastrointest Endosc 1997;46:212-216.
11. Akohoshi K, Chijiiwa Y, Saski I et al. Preoperative TN staging of gastric cancer using a 15 MHz ultrasound miniprobe. Br J Radiol 1997;70:703-707.
12. Asencio F, Aguilo J, Salvador JL, et al. Video-laparoscopic staging of gastric cancer. A prospective multicenter comparison with non invasive techniques. Surg Endosc 1997; 11:1153-1138.
13. Burke EC, Karpeh MS, Conlon KC, Brennan MF. Laparoscopy in the management of gastric adenocarcinoma. Ann Surg 1997;225:262-267.
14. D'Ugo DM, Persiani R, Caracciolo F, Ronconi P, Coco C, Picciocchi A. Selection of locally advanced gastric carcinoma hy preoperative staging laparoscopy. Surg Endosc 1997;11:1159-1162.
15. Feussner H, Kraemer SJM, Siewert JR. Staging laparoscopy. Chirurg 1997;68: 201-209.
16. Charukhchyan SA. Lesser sac endoscopy in gastric carcinoma : operability assessment. Surg Laparosc Endosc 1998;8:9-13.
17. Yu W, Choi GS, Whang I, Suh IS. Comparison of five systems for staging lymph node metastasis in gastric cancer. Br J Surg 1997;84:1305-1309.
18. Elias D. Vers une standardisation des procédures chirurgicales et anatomo-pathologiques d'étude des ganglions au cours des gastrectornies pour cancer. Hepato-Gastro 1997;4:407-415.
19. Wang CS, Hsueh S, Chao TC et al. Prognotic study of gastric cancer without serosal invasion : reevaluation of the definition of early gastric cancer. J Am Coll Surg 1997;185:476-480.
20. Hanazaki K, Wakabayashi M, Sodeyama H, et al. Surgical outcome in early gastric cancer with lymph node metastasis. Hepatogastroenterology 1997;44:907-911.
21. Noda M, Kodama T, Atsumi M et al. Possibilities and limitations of endoscopic resection for early gastric cancer. Endoscopy 1997;5:361-365.
22. Korenaga D, Orita H, Maekawa A et al. Pathological appearance of the stomach after endoscopic mucosal resection for early gastric cancer. Br J Surg 1997;84:1563-1569.
23. Tanaka M, Inatsuchi S. A four-point fixation method for resection of early gastric cancer, with particular reference to the analysis of cases of incomplete resection. Surg Endosc 1997;11:295-298.
24. Everett SM, Axon AT. Early gastric cancer in Europe. Gut 1997;41:142-150.
25. Takeshita K, Tani M, Honda T et al. Treatment of primary multiple early gastric cancer : from the viewpoint of clinicopathologic features. World J Surg 1997;21:832-836.
26. Seto Y, Nagawa H, Muto T. Intra-operative diagnosis of N2 lymph node metastasis of gastric cancer. Hepatogastroenterology 1997; 44:838-841.
27. Seto Y, Nagawa H, Muto T. Results of extended lymph node dissection for gastric cancer cases with N2 lymph node metastasis. Int Surg 1997;82:257-261.
28. Volpe CM, Driscoll DL, Miloro SM, Douglas HO Jr. Survival benefit of extended D2 resection for proximal gastric cancer. J Surg Oncol 1997;64:231-236.
29. Deguili M, Sasako M, Ponzetto A, et al. Extended lymph node dissection for gastric cancer : results of a prospective, multi-centre analysis of morbidity and mortality in 118 consecutive cases. Eur J Surg Oncol 1997;23: 310-314.
30. Sasako M. Risk factors for surgical treatment in the Dutch gastric cancer trial. Br J Surg 1997;84:1567-1571.
31. Wanebo HI, Kennedy BJ, Winchester DA, Stewart KA, Fremgen AM. Role of splenectomy in gastric cancer : adverse effect of elective splenectomy on longterm survival. J Am Coll Surg 1997;185:177-184.
32. Ishigami S, Natsugoe S, Saihara T et al. Clinical and pathologic features of early gastric cancer in elderly patients. Hepatogastroenterology 1997;44:1164-1168.
33. Uemura T, Otani J, Kawasaki S, et al. Surgery of gastric cancer in patients over 80 years old. Acta Med Okayama 1997;51:159-165.
34. Dutch Gastric Cancer Group. Lymph node dissection in gastric cancer : 5-year results of a randomized trial of D1 and D2 dissection in 996 Dutch patients. ASCO 1997.
35. Kodama I, Takamiya H, Mizutani K et al. Gastrectomy with combined resection of other organs for carcinoma of the stomach with invasion to adjacent organs : clinical efficacy in retrospective study. J Am Coll Surg 1997;184:16-22.
36. Isozaki H, Okajima K, Ichinona T, Ichinona T, Hara H, Fujii K, Nomura E. Risk factors of esophagojejunal anastomotic leakage after total gastrectomy for gastric cancer. Hepatogastroenterology 1997;44:1509-1512.
37. Karpeh MS, Kelsen DP. Combined modality therapy of gastric cancer. Surg Oncol Clin N Am 1997;6:741-747.
38. Cascinu S, Labianca R, Alessandroni P et al. Intensive weekly chemotherapy for advance gastric cancer fluorouracil, cisplatin, epidoxorubicin, 6S-leucovorin, glutathion and filgrastim : a report from the Italian Group for the study of Digestive Tract Cancer. J Clin Oncol 1997;15:3313-3319.
39. Park Jo, Chung HC, Cho JY et al. Retrospective comparison of infusional 5-fluorouracil, doxorubicin and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancer. Am J Clin Oncol 1997;20:484-489.
40. Crookes P, Leichman CG, Leichman L, et al. Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: final report. Cancer 1997;79: 1767-1775.
41. Topal B, Trimpeneers F, Hendrickx J. Prognosis of gastric carcinoma with emphasis on lymph node status. Acta chur bel 1997; 97:118-122.
42. Lisborg PH, Jatzko GR, Denk H, Klimpfinger MH, Stettner HM. Long-term survival analysis of gastric cancer limited to subserosa. Z Gastroenterol 1997;35:663-668.
43. Wu CW, Hsieh MC, Lo SS, et al. Prognostic indicators for survival after curative resection for patients with carcinoma of the stomach. Dig Dis Sci 1997;42:1265-1269.
44. Harrison LE, Karpeh MS, Brennan MF. Proximal gastric cancers resected via a transabdominal-only approach. Results and comparisons to distal adenocarcinoma of the stomach. Ann Surg 1997;225:678-685.
45. Pectasides D, Mylonakis A, Kostopoulou M, Papadopoulou M, Triantafillis D, Varthalitis D. CEA, CA 19-9 and CA-50 in monitoring gastric carcinoma. Am J Clin Oncol 1997;20: 348-353.
46. Nishiyama M, Toge T. Selection of adjuvant chemotherapy for gastric cancer using objective criteria. Gan To Kagaku Ryoho 1997;24 (Suppl 1):232-238.
47. Muller W, Schneiders A, Heider KH, Meier S, Hommel G, Gabbert HE. Expression and prognostic value of the CD44 splicing variants v5 and v6 in gastric cancer. J Pathol 1997;183:222-227.
48. Nakamura M, Katano M, Fujimoto K, Morisaki T. A New Prognostic Strategy for gastric Carcinoma : mRNA expression of Tumor Growth-Related Factors in endoscopic Biopsy Specimens. Ann Surg 1997;226: 35-42.
49. Wurl P, Weigmann F, Meye A et al. Detection of P53 autoantibodies in sera of gastric cancer patients and their prognostic relevance. Scand J Gastroenterol 1997;32:1147-1151.
50. Wu CC, Chen JT, Chang MC, et al Optimal surgical strategy for potentially curable serosa-involved gastric carcinoma with intraperitoneal free cells. J Am Coll Surg 1997;184:611-617.